BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18638169)

  • 1. Intravenous catheter infections in pulmonary arterial hypertension.
    Gaine S; Gomberg-Maitland M
    Int J Clin Pract Suppl; 2008 Jul; (160):3-4. PubMed ID: 18638169
    [No Abstract]   [Full Text] [Related]  

  • 2. Central venous access device associated infections: recommendations for best practice in home infusion therapy.
    Gorski LA
    Home Healthc Nurse; 2010 Apr; 28(4):221-9. PubMed ID: 20520262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension.
    Doran AK; Ivy DD; Barst RJ; Hill N; Murali S; Benza RL;
    Int J Clin Pract Suppl; 2008 Jul; (160):5-9. PubMed ID: 18638170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.
    Ivy DD; Calderbank M; Wagner BD; Dolan S; Nyquist AC; Wade M; Nickels WM; Doran AK
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):823-9. PubMed ID: 19637961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of catheter-related infections using a closed hub system in patients with pulmonary arterial hypertension.
    Akagi S; Matsubara H; Ogawa A; Kawai Y; Hisamatsu K; Miyaji K; Munemasa M; Fujimoto Y; Kusano KF; Ohe T
    Circ J; 2007 Apr; 71(4):559-64. PubMed ID: 17384460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transition from intravenous to subcutaneous prostacyclin in pulmonary hypertension].
    Escribano Subías P; Cea-Calvo L; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
    Rev Esp Cardiol; 2003 Aug; 56(8):818-21. PubMed ID: 12892628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of Micrococcus luteus isolates from blood cultures of patients with pulmonary hypertension receiving epoprostenol continuous infusion.
    Hirata Y; Sata M; Makiuchi Y; Morikane K; Wada A; Okabe N; Tomoike H
    J Infect Chemother; 2009 Dec; 15(6):424-5. PubMed ID: 20012737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension.
    Oudiz RJ; Widlitz A; Beckmann XJ; Camanga D; Alfie J; Brundage BH; Barst RJ
    Chest; 2004 Jul; 126(1):90-4. PubMed ID: 15249447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infections in patients given treatment with intravenous prostanoids.
    Kallen AJ; Lederman E; Balaji A; Trevino I; Petersen EE; Shoulson R; Saiman L; Horn EM; Gomberg-Maitland M; Barst RJ; Srinivasan A
    Infect Control Hosp Epidemiol; 2008 Apr; 29(4):342-9. PubMed ID: 18462147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of catheter-related complications in patients with advanced pulmonary arterial hypertension undergoing continuous epoprostenol infusion.
    Nagai T; Kohsaka S; Anzai T; Yoshikawa T; Fukuda K; Sato T
    Chest; 2012 Jan; 141(1):272-273. PubMed ID: 22215838
    [No Abstract]   [Full Text] [Related]  

  • 11. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
    Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
    Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):170-2. PubMed ID: 17332729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and antimicrobial effectiveness of treprostinil sodium in Sterile Diluent for Flolan.
    Zaccardelli D; Phares K; Jeffs R; Doran A; Wade M
    Int J Clin Pract; 2010 Jun; 64(7):885-91. PubMed ID: 20584221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Micrococcus blood stream infection in patients receiving epoprostenol].
    Mitsutake K; Nogami T
    Kansenshogaku Zasshi; 2005 Oct; 79(10):829-30. PubMed ID: 16296331
    [No Abstract]   [Full Text] [Related]  

  • 15. Indwelling central venous catheter--related infections and two different procedures of catheter care.
    Jones PM
    Cancer Nurs; 1987 Jun; 10(3):123-30. PubMed ID: 3502913
    [No Abstract]   [Full Text] [Related]  

  • 16. The "bouncing" catheter.
    Malaczynska-Rajpold K; Kurzyna M; Koteja A; Torbicki A; Mularek-Kubzdela T
    Cardiol J; 2016; 23(5):552-553. PubMed ID: 27723062
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion.
    Selimovic N; Andersson B; Bergh CH; Sakiniene E; Carlsten H; Rundqvist B
    J Heart Lung Transplant; 2009 Aug; 28(8):808-14. PubMed ID: 19632577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current issues in central venous catheter infection.
    Toltzis P; Goldmann DA
    Annu Rev Med; 1990; 41():169-76. PubMed ID: 2184721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome.
    Mouw E; Chessman K; Lesher A; Tagge E
    J Pediatr Surg; 2008 Jun; 43(6):1025-9. PubMed ID: 18558177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular access device choices for home care patients.
    Steinheiser MM
    Caring; 1995 May; 14(5):14-5. PubMed ID: 10142347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.